Robert Driscoll
Stock Analyst at Wedbush
(4.53)
# 997
Out of 4,501 analysts
347
Total ratings
46.7%
Success rate
12%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Robert Driscoll
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| REPL Replimune Group | Reiterated: Hold | $6 → $9 | $10.99 | -18.11% | 18 | Jun 30, 2026 | |
| TYRA Tyra Biosciences | Reiterated: Buy | $53 | $32.75 | +61.83% | 15 | Jun 16, 2026 | |
| KURA Kura Oncology | Reiterated: Buy | $36 | $11.45 | +214.41% | 30 | Jun 15, 2026 | |
| IDYA IDEAYA Biosciences | Reiterated: Buy | $58 | $36.99 | +56.80% | 25 | Jun 12, 2026 | |
| CGEM Cullinan Therapeutics | Maintained: Buy | $37 | $18.13 | +104.08% | 18 | Jun 11, 2026 | |
| CTMX CytomX Therapeutics | Reiterated: Buy | $11 | $3.76 | +192.55% | 18 | Jun 4, 2026 | |
| CBIO Crescent Biopharma | Maintained: Buy | $27 | $17.34 | +55.71% | 5 | Jun 1, 2026 | |
| BDTX Black Diamond Therapeutics | Maintained: Buy | $14 | $1.91 | +632.98% | 14 | Jun 1, 2026 | |
| RVMD Revolution Medicines | Reiterated: Buy | $165 | $186.88 | -11.71% | 23 | Jun 1, 2026 | |
| CRBP Corbus Pharmaceuticals Holdings | Reiterated: Buy | $38 → $30 | $9.68 | +209.92% | 6 | May 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $6 | $2.67 | +124.72% | 2 | May 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $80 | $75.24 | +6.33% | 4 | May 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $29 → $34 | $19.21 | +76.99% | 4 | May 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $7 → $6 | $0.745 | +705.37% | 8 | May 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $19 → $33 | $31.06 | +6.25% | 11 | May 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $11 | $8.27 | +33.01% | 26 | May 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | $7 → $5 | $10.58 | -52.74% | 3 | May 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10 | $5.95 | +68.07% | 14 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $76 → $36 | $16.40 | +119.51% | 10 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $37 | $23.04 | +60.59% | 10 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $41 | $28.92 | +41.77% | 23 | Apr 22, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $80 → $25 | $8.83 | +183.13% | 9 | Mar 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $6 → $1 | $0.403 | +148.14% | 4 | Dec 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $4 | $4.88 | -18.03% | 13 | Aug 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $27 | $6.52 | +314.11% | 1 | Jul 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $7 → $6 | $1.50 | n/a | 14 | May 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $8 | $2.33 | n/a | 4 | Aug 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $67 | $129.83 | n/a | 1 | Nov 19, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $7 → $6 | $4.80 | n/a | 8 | Mar 8, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $8 | $15.67 | n/a | 4 | Oct 5, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $7 → $10 | $0.0001 | n/a | 2 | Mar 19, 2020 |
Replimune Group
Jun 30, 2026
Reiterated: Hold
Price Target: $6 → $9
Current: $10.99
Upside: -18.11%
Tyra Biosciences
Jun 16, 2026
Reiterated: Buy
Price Target: $53
Current: $32.75
Upside: +61.83%
Kura Oncology
Jun 15, 2026
Reiterated: Buy
Price Target: $36
Current: $11.45
Upside: +214.41%
IDEAYA Biosciences
Jun 12, 2026
Reiterated: Buy
Price Target: $58
Current: $36.99
Upside: +56.80%
Cullinan Therapeutics
Jun 11, 2026
Maintained: Buy
Price Target: $37
Current: $18.13
Upside: +104.08%
CytomX Therapeutics
Jun 4, 2026
Reiterated: Buy
Price Target: $11
Current: $3.76
Upside: +192.55%
Crescent Biopharma
Jun 1, 2026
Maintained: Buy
Price Target: $27
Current: $17.34
Upside: +55.71%
Black Diamond Therapeutics
Jun 1, 2026
Maintained: Buy
Price Target: $14
Current: $1.91
Upside: +632.98%
Revolution Medicines
Jun 1, 2026
Reiterated: Buy
Price Target: $165
Current: $186.88
Upside: -11.71%
Corbus Pharmaceuticals Holdings
May 27, 2026
Reiterated: Buy
Price Target: $38 → $30
Current: $9.68
Upside: +209.92%
May 18, 2026
Reiterated: Buy
Price Target: $6
Current: $2.67
Upside: +124.72%
May 18, 2026
Reiterated: Buy
Price Target: $80
Current: $75.24
Upside: +6.33%
May 14, 2026
Reiterated: Buy
Price Target: $29 → $34
Current: $19.21
Upside: +76.99%
May 14, 2026
Reiterated: Buy
Price Target: $7 → $6
Current: $0.745
Upside: +705.37%
May 14, 2026
Reiterated: Buy
Price Target: $19 → $33
Current: $31.06
Upside: +6.25%
May 13, 2026
Maintained: Hold
Price Target: $11
Current: $8.27
Upside: +33.01%
May 12, 2026
Maintained: Sell
Price Target: $7 → $5
Current: $10.58
Upside: -52.74%
May 8, 2026
Reiterated: Buy
Price Target: $10
Current: $5.95
Upside: +68.07%
May 8, 2026
Reiterated: Buy
Price Target: $76 → $36
Current: $16.40
Upside: +119.51%
May 8, 2026
Maintained: Buy
Price Target: $37
Current: $23.04
Upside: +60.59%
Apr 22, 2026
Reiterated: Buy
Price Target: $41
Current: $28.92
Upside: +41.77%
Mar 13, 2026
Reiterated: Buy
Price Target: $80 → $25
Current: $8.83
Upside: +183.13%
Dec 19, 2025
Downgraded: Hold
Price Target: $6 → $1
Current: $0.403
Upside: +148.14%
Aug 7, 2025
Maintained: Hold
Price Target: $4
Current: $4.88
Upside: -18.03%
Jul 14, 2025
Initiated Coverage: Buy
Price Target: $27
Current: $6.52
Upside: +314.11%
May 8, 2025
Maintained: Buy
Price Target: $7 → $6
Current: $1.50
Upside: n/a
Aug 14, 2024
Reiterated: Buy
Price Target: $8
Current: $2.33
Upside: n/a
Nov 19, 2021
Maintained: Buy
Price Target: $67
Current: $129.83
Upside: n/a
Mar 8, 2021
Maintained: Buy
Price Target: $7 → $6
Current: $4.80
Upside: n/a
Oct 5, 2020
Maintained: Buy
Price Target: $8
Current: $15.67
Upside: n/a
Mar 19, 2020
Downgraded: Hold
Price Target: $7 → $10
Current: $0.0001
Upside: n/a